Candel Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CADL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -6.57 M-5.81 M-8.62 M-8.89 M-10.24 M -33.56 M Cash from investing activities 0-3 000-3 000-31 K-117 K -154 K Cash from financing activities 1.68 M91.91 M-1.87 M17.44 M-3.37 M 104.12 M Free cash flow -6.57 M-5.82 M-8.62 M-8.92 M-10.38 M -33.74 M

Notizie

Paul Manning acquista azioni Candel Therapeutics (CADL) per 3 mln $

Le azioni Candel Therapeutics calano dopo il pricing dell’offerta da 100 milioni di dollari

Candel Therapeutics stock falls on $100 million offering pricing

Why Is Candel Therapeutics Stock Falling Friday? - Candel Therapeutics (NASDAQ:CADL)

New Strong Sell Stocks for January 20th

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Candel Therapeutics (NASDAQ:CADL), Centene (NYSE:CNC)

Obiettivo di prezzo di Candel Therapeutics alzato a $14 da Freedom Capital

Candel Therapeutics stock price target raised to $14 by Freedom Capital

Candel Therapeutics to present phase 3 prostate cancer trial data at SITC

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards - Trinity Cap (NASDAQ:TRIN)

Candel Therapeutics secures $130 million term loan facility

Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now